Therapy Areas: Respiratory
Maverix Medical's Narwhal Cryo System receives FDA 510(k) clearance
21 August 2026 - Maverix Medical, a healthcare company focused on improving the diagnosis and treatment of lung cancer, announced on Thursday that the US Food and Drug Administration (FDA) granted 510...
Pillar Biosciences, LC-SCRUM-Asia and LSI Medience collaborate for liquid biopsy screening in lung cancer
20 August 2026 - US-based biotechnology company Pillar Biosciences Inc announced on Wednesday a collaboration with LC-SCRUM-Asia, a lung cancer screening project, and LSI Medience Corporation, a Japan...
Vascarta commences NIH phase I clinical study of VAS-101 in sickle cell disease
20 August 2026 - Pharmaceutical company Vascarta Inc announced on Wednesday that a second proof of concept phase I clinical study of VAS-101 (Vasceptor; topical curcumin gel) in sickle cell disease (S...
Azra AI and 4DMedical partner on lung health intelligence
17 August 2026 - Healthcare enterprise platform Azra AI and 4DMedical Limited (ASX: 4DX), a provider of quantitative lung imaging analytics, on Monday announced a strategic OEM and reseller partnershi...
AstraZeneca reports positive Phase III results for Tagrisso and Orpathys
17 August 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing Tagrisso (osimertinib...
HUTCHMED reports positive Phase III results for ORPATHYS and TAGRISSO combination
17 August 2026 - Biopharmaceutical company HUTCHMED (China) Limited (Nasdaq: HCM) (AIM: HCM) (HKEX: 13) on Monday announced positive high-level results from the SAFFRON Phase III trial, showing that O...